Healthcare -
Biotechnology - NASDAQ - US
$ 40.61
0.794 %
$ 2.63 B
Market Cap
-17.35
P/E
KYMR - NET CHANGE IN CASH
Net Change in Cash KYMR - Kymera Therapeutics, Inc.
41.3 M
LAST VALUE
38.52%
2 YEAR CAGR
4.12%
5 YEAR CAGR
0.00%
10 YEAR CAGR